2026-01-28 - Analysis Report
**Company Overview**
Align Technology is a medical device company that provides clear aligners and other oral care products for dental and orthodontic applications.

**Return Rate Comparison**
| Metric | ALGN | VOO |
|--------|------|-----|
| Cumulative Return | -16.68% | 128.51% |
| Divergence | 144.00 | - |

The cumulative return of Align Technology (ALGN) is significantly lower than that of the S&P 500 (VOO) as of the last day of the data. The divergence between the two stocks indicates a relative difference of 4.50% in their max-min fluctuation range.

**Alpha, Beta Analysis**
| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------|------|-----|-------|------|--------|
| 2016-2018 | 65.0% | 48.7% | 57.0% | 1.5 | 15.2B |
| 2017-2019 | 79.0% | 51.1% | 54.0% | 1.6 | 20.2B |
| 2018-2020 | 81.0% | 56.9% | 58.0% | 1.5 | 38.7B |
| 2019-2021 | 166.0% | 53.3% | 101.0% | 1.5 | 47.6B |
| 2020-2022 | -70.0% | 73.3% | -74.0% | 1.5 | 15.3B |
| 2021-2023 | -195.0% | 73.3% | -213.0% | 1.7 | 19.9B |
| 2022-2024 | -169.0% | 65.1% | -198.0% | 1.7 | 15.1B |
| 2023-2025 | -62.0% | 60.0% | -138.0% | 1.5 | 11.3B |

The data shows significant fluctuations in the stock's performance over the years, with varying levels of Alpha and Beta. The Alpha values reflect the company's return relative to the market, indicating potential outperformance in some periods and underperformance in others.

**Recent Stock Price Fluctuations**
| Metric | Value |
|--------|-------|
| Close | $167.04 |
| Last-market | -0.36% |
| 5-day SMA | $168.46 |
| 20-day SMA | $166.42 |
| 60-day SMA | $154.33 |

The recent stock price fluctuations indicate a slight decline in the stock price, with the 5-day SMA and 20-day SMA above the current price, and the 60-day SMA below the current price.

**RSI, PPO, and Delta Relative Divergence Analysis**
| Metric | Value |
|--------|-------|
| RSI | 48.80 |
| PPO | -0.50 |
| Hybrid Signal: Buy (Cash 0%) | |
| Risk Level: Medium (MRI 0.70) | |
| 7-day Rank change | 11 (+) |
| 7-day Dynamic Expected Return change | 556.80 (+) |

The RSI and PPO values indicate a medium level of volatility, with a risk level of Medium (MRI 0.70). The Hybrid Signal suggests a Buy with no cash allocation. The recent rank change and dynamic expected return change indicate an improving trend.

**Expected Return**
-951.50%

The expected return of -95.15% indicates a potential long-term performance of less than a dollar invested for every dollar today, assuming the S&P 500 is used as a benchmark.

**Recent News & Significant Events**

* 2026-01-26: How Investors Are Reacting To Align Technology (ALGN) Margin Roadmap and New 0x3 Treatment Suite (simplywall.st)
* 2026-01-22: Assessing Align Technology (ALGN) Valuation After Recent Share Price Momentum And Mixed Signals (Yahoo Finance)
* 2026-01-27: 2 Unpopular Stocks That Deserve Some Love and 1 We Brush Off (The Globe and Mail)
* 2026-01-19: Align Technology Q4 Preview: Even After A Big Drop In Price, Itâ€™s Too Expensive (ALGN) (Seeking Alpha)
* 2026-01-23: Piper Sandler reiterates Overweight rating on Align Technology stock (Investing.com)
* 2025-10-30: ALGN Stock Up on Q3 Earnings and Revenue Beat, Margins Crash (Zacks Investment Research)

These recent news and events may have impacted the stock price and performance.

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
- Opinions: 15
- Target Price (avg/high/low): 183.87 / 220.00 / 150.00

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|------|-----|---------|
| 2025-11-05 | 0.78 | 1.00B$ |
| 2025-08-06 | 1.72 | 1.01B$ |
| 2025-05-08 | 1.27 | 0.98B$ |
| 2024-11-05 | 1.55 | 0.98B$ |
| 2025-11-05 | 1.55 | 0.98B$ |

The recent earnings analysis shows a mixed performance, with varying EPS and revenue figures.

**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.00B | 64.20% |
| 2025-06-30 | $1.01B | 69.94% |
| 2025-03-31 | $0.98B | 69.45% |
| 2024-12-31 | $1.00B | 70.03% |
| 2024-09-30 | $0.98B | 69.72% |

The revenue and profitability data indicates stable revenue figures, with varying profit margins.

**Capital and Profitability**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $3.96B | 1.43% |
| 2025-06-30 | $3.91B | 3.18% |
| 2025-03-31 | $3.79B | 2.46% |
| 2024-12-31 | $3.85B | 2.69% |
| 2024-09-30 | $3.94B | 2.94% |

The capital and profitability data shows increasing equity and relatively stable ROE (Return on Equity) figures.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.